IDEAYA Biosciences(IDYA)

SOUTH SAN FRANCISCO, CA

Biotechnology2 H-1B visas (FY2023)

Website LinkedIn Careers Page

Focus: Personalized Synthetic Medicines

IDEAYA Biosciences is a life sciences company focused on Personalized Synthetic Medicines.

Oncology

Funding Stage

PUBLIC

Employees

501-1000

Open Jobs

Pipeline & Clinical Trials

IDE397

Solid Tumor

Phase 1

Clinical Trials (1)

NCT04794699Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

Phase 1

IDE-161

Advanced or Metastatic Solid Tumors

Phase 1

IDE892

NSCLC Adenocarcinoma

Phase 1

Clinical Trials (1)

NCT07277413A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Phase 1

IDE849

Small-cell Lung Cancer

Phase 1/2

Clinical Trials (1)

NCT07174583A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

Phase 1/2

GSK4418959

Neoplasms, Colorectal

Phase 1/2

Clinical Trials (1)

NCT06710847A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

Phase 1/2

IDE196

Metastatic Uveal Melanoma

Phase 1/2

Clinical Trials (1)

NCT03947385Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Phase 1/2

Darovasertib

Uveal Melanoma

Phase 2

Clinical Trials (1)

NCT05907954(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

Phase 2

IDE196

Metastatic Uveal Melanoma

Phase 2/3

Clinical Trials (1)

NCT05987332IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma

Phase 2/3

Darovasertib

Uveal Melanoma

Phase 3

Clinical Trials (1)

NCT07015190Neoadjuvant Darovasertib in Primary Uveal Melanoma

Phase 3

Open Jobs (31)

Interview Prep Quick Facts

Portfolio: 9 clinical trials

Top TAs: Oncology

H-1B (2023): 2 approvals

SEC Filings: 2 available

Open Roles: 31 active jobs

Therapeutic Area Focus

Oncology

8 pipeline

Marketed

Pipeline

Financials (FY2025)

Revenue

$23M54%

R&D Spend

$130M(554%)45%

Net Income

-$113M

Cash

$157M

Source: SEC 10-K Filing

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

IDEAYA Biosciences(IDYA)

Pipeline & Clinical Trials

Open Jobs (31)

Director, Payroll

Senior Employee Relations Manager

Director, Data Standards & Statistical Programming

Senior Medical Science Liaison (MidAtlantic-PA,MD,DC)

Senior Medical Science Liaison (South East - NC, SC, TN, GA)

Director, Commercial Supply Chain

Senior Director, Regulatory CMC

Director, Intellectual Property

Senior Patent Agent

Counsel

Senior Medical Director, Patient Safety & Pharmacovigilance

Vice President, Antibody Drug Conjugate (ADC) Development and Manufacturing

Director, Financial Planning & Analysis, Clinical & Development

Senior Principal Research Scientist, Computational Chemistry

Medical Director, Drug Safety and Pharmacovigilance

Senior Director, Health Economics and Outcomes Research / Real World Evidence

Drug Safety Manager, Drug Safety Compliance and Vendor Oversight

Senior Manager, Drug Safety Operations

Senior Director, Trade, Channel, & Distribution

Senior Medical Director, Late Development

Director, Field Operations & Data Management

Director, Market Research and Competitive Intelligence

Director, Clinical Science

Senior Medical Science Liaison (West - CA)

Director, Medicinal Chemistry

Financials (FY2025)

Hiring Trend

Visa Sponsorship